Serotonin (5-hydroxytryptamine, 5-HT) is widely distributed in the central nervous, gastrointestinal, and cardiovascular systems as a neurotransmitter, neuromodulator and hormone.
distributed from the esophagus to the colon in the gastrointestinal system, and is especially closely related with regulation of gastrointestinal motility. 7) For these reasons, 5-HT 4 agonists are expected to be effective for treatment of gastrointestinal dysfunctions such as diarrhea, constipation, gastroparesis, ileus, reflux esophagitis, and pseudo-obstructions.
Most of the reported 5-HT 4 agonists, except for 5-HT derivatives, 8, 9) have a benzamide (or other arylcarboxamide) skeleton, 7) but many possess poor selectivity for the 5-HT 4 receptor due to 5-HT 3 antagonistic activity.
In order to find new 5-HT 4 agonists, we focused on the linker group of the benzamide and synthesized 3-(4-amino-5-chloro-2-methoxyphenyl)-1,2,4-oxadiazole derivatives, derived from the Merck 5-HT 3 antagonist 1 possessing an oxadiazole ring (Chart 1). 10) Consequently, it was found that a 1,2,4-oxadiazole ring could function as a linker group instead of an amide bond for 5-HT 4 agonists as well as for 5-HT 3 antagonists. Among such derivatives, cyclic amine derivatives (quinuclidines, hexahydropyrrolizines, piperidines, pyrrolidines) having a basic nitrogen atom at the g-position from oxadiazole showed potent 5-HT 4 agonistic activity in the longitudinal muscle myenteric plexus (LMMP) preparation of guinea pig ileum, and especially 3-piperidylmethyl derivative (2) showed a unique profile. In this paper, we report the synthesis, potency, and receptor selectivity of (S)-2-chloro-5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3-yl]aniline [2(S)] as a 5-HT 4 agonist.
The oxadiazole derivatives were synthesized as follows (Chart 2). Benzamide (4), prepared from benzotriazolyl ester (3) 11) and aqueous ammonia in N,N-dimethylformamide (DMF), was converted into nitrile (5) by dehydration with phosphorus oxychloride. N-Hydroxybenzamidine (6), obtained from 5 and hydroxylamine in refluxing ethanol, was cyclized with aminoesters in the presence of sodium hydride in DMF to afford 3-(4-amino-5-chloro-2-methoxyphenyl)-1,2,4-oxadiazole derivatives. Racemic compound 2(RS) was obtained from methyl 2-piperidineacetate, and its optical isomers [2(S), 2(R)] were separated by optical resolution of the correspond ditoluoyltartaric acid salts recrystallized from DMF-H 2 O. The absolute configuration of 2(S) grown from AcOEt-EtOH was determined on the basis of X-ray structure analysis.
Receptor selectivities of 2(S), 2(R), and cisapride 12) were evaluated by the binding affinities using guinea pig 5-HT 4 receptor, rat 5-HT 3 receptor, and cloned human 5-HT 3 13) and 5-HT 4 receptors, 14) and 5-HT 4 agonistic activities were measured by LMMP preparation (Table 1) . [15] [16] [17] Whereas Schiavi et al. previously reported the receptor selectivity of 5-HT 4 agonists, 18) only cisapride and SC-53116 showed higher affinities for the 5-HT 4 receptor (pig caudate nucleus) than the 5-HT 3 receptor (NG 108-15 hybrid cells), and the 5-HT 3 /5-HT 4 K i ratios were 4.2 and 2.5, respectively. 18) In our study, the S isomer 2(S) (YM-53389) showed 9 times higher affinity for the 5-HT 4 receptor than the 5-HT 3 receptor in guinea pig and rat, whereas 2(R) showed the opposite selectivity. YM-53389 retained high affinity for the human 5-HT 4 receptor but had no affinity for the human 5-HT 3 receptor. The receptor selectivity of YM-53389 was vastly superior to that of cisapride in our binding study, and this compound showed a potent stimulatory effect for 5-HT 4 agonistic activ-ity in the LMMP preparation.
Next, the binding affinities for other receptors were measured to reveal the pharmacological profile of 2(RS) and cisapride ( Table 2 ). All receptor binding studies were performed by standard procedures using standard assay conditions. As a result, 2(RS) showed only weak affinity for the sigma receptor, but no affinity to other 5-HT receptor subtypes and the receptors of other transmitters. These results indicate that YM-53389 is a highly selective 5-HT 4 receptor ligand. This compound is undergoing further evaluation due to the structural novelty, in comparison to benzamide YM-47813, described in the preceding report and to its good pharmacological properties.
Experimental
All melting points were determined on a Yanaco MP-500D melting point apparatus and are uncorrected.
1 H-NMR spectra were measured with a JEOL FX90Q, a FX100, a FX270 or FX400 spectrometer; chemical shifts are reported in d units using tetramethylsilane as internal standard and the following abbreviations are used: sϭsinglet, dϭdoublet, tϭtriplet, qϭquar-tet, mϭmultiplet, ddϭdouble doublet, dtϭdouble triplet, brϭbroad. Mass spectra were recorded with a Hitachi M-80 electron impact (EI), JEOL JMS-DX300 (FAB) spectrometer or Hewlett Packard 5970 MSD (GC) spectrometer. Elemental analyses were performed with a Yanaco MT-5. All organic extracts were dried over anhydrous magnesium sulfate and concentrated with a rotary evaporator under reduced pressure.
4-Amino-5-chloro-2-methoxybenzamide (4) Twenty ml of 29% aqueous ammonia was added to a solution of benzotriazolyl 4-amino-5-chloro-2-methoxybenzoate (3) (6.36 g, 20 mmol) in DMF (300 ml) at room temperature and the resulting mixture was stirred for 30 min. The reaction mixture was concentrated and the residue was diluted with AcOEt and aqueous K 2 CO 3 solution. The precipitates were collected by filtration and washed afford 4 as a beige solid (3.65 g, 91%) . 
4-Amino-5-chloro-2-methoxybenzonitrile (5)
A suspension of 4 (11.00 g, 55 mmol) in phosphorus oxychloride (50 ml) was stirred at 50°C for 30 min. The reaction mixture was concentrated and the residue was diluted with H 2 O and made alkaline by K 2 CO 3 . This mixture was extracted with AcOEt. The extract was washed with brine, dried, and concentrated. The residue was crystallized from hexane-AcOEt and 5 was obtained as a beige solid (7.46 g, 75%). -5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3 -yl]-aniline (2) A solution of 6 (2.15 g, 10 mmol) in DMF (7 ml) was added dropwise into a suspension of methyl 2-(2-piperidyl)acetate (2.04 g, 13 mmol), and 60% sodium hydride (in oil) (0.50 g, 12.5 mmol ) in DMF (15 ml) under water-cooling. The reaction mixture was stirred for 1 h at room temperature. The mixture was then quenched with ice and concentrated. The residue was diluted with water and extracted with AcOEt. The extract was washed with brine, dried, and concentrated. The residue was chromatographed on SiO 2 eluting with CHCl 3 -MeOH (10 : 1) to afford 2 as a white solid (2.32 g, 72%). mp 101-103°C (AcOEt-hexane). ) and L-ditoluoyltartaric acid (57.5 g, 149 mmol) in DMF (750 ml) was warmed at 50°C and dissolved. After removing the oil bath, H 2 O (1000 ml) was added to the solution and the resulting mixture was gradually cooled to room temperature and allowed to stand overnight. Precipitate was collected and recrystallized from DMF-H 2 O (1 : 1) (total: 3 recrystallizations). The L-ditoluoyltartaric acid salt of 2(R) was added to a mixture of 1 N HCl (80 ml) and AcOEt (100 ml) and stirred for 2 h. The mixture was extracted with diluted HCl. The water layer was made alkaline with K 2 CO 3 and extracted with CHCl 3 -MeOH (10 : 1). The extract was washed with brine, dried, and concentrated. To the residue in EtOH (100 ml) was added 4 N HCl-AcOEt solution (15 ml) and AcOEt (50 ml), and the mixture allowed to stand overnight at room temperature. The precipitate was collected to afford the HCl salt of 2(R) (16.53 , F 000 ϭ752.00, CuK a radiation, graphite-monochromated, lϭ1.54178 Å.
2-Chloro
Structure Solution and Refinement: The structure was solved by a direct method using SAPI91, and the final refinement was done by the full-matrix least-squares method with anisotropic thermal parameters for all non-hydrogen atoms and fixed isotropic thermal parameters for all hydrogen atoms. The final R value was 0.047. The absolute configuration was determined to be S using the method described by Flack [cϭ0.01 (1)].
